Clinical Trial Update: A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated MGD020 alone or with MGD014 in people with HIV-1 infection on antiretroviral therapy. Results were posted on 2025-03-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• MGD014 (MGD014)
• MGD020 (MGD020)

Snippet

Sponsor: MacroGenics | Conditions: Human Immunodeficiency Virus I Infection, Immunodeficiency Virus Type 1, Human | Phase 1 | Status: COMPLETED | Results posted: 2025-03-28